Skip to content
Open in App
Hubei Hongyuan Pharmaceutical

Hubei Hongyuan Pharmaceutical

web2

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces an...

Stage
Undisclosed
Funding
Undisclosed
Team
0
0.0Mission ScoreFixed 0-100 scale

About

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.

Expert Insight
Hubei Hongyuan Pharmaceutical profile.

Expert Coverage

No published expert evaluations are available for this project yet.

PharmaceuticalsHealthcare
0team
0evaluations
0subscribers